Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque. Marfella R, Prattichizzo F, Sardu C, Paolisso P, et al. Atherosclerosis 2023 Jun 29:117180. doi: 10.1016/j.atherosclerosis.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Marfella R, Prattichizzo F, Sardu C, Paolisso P, et al. Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque. Atherosclerosis 2023 Jun 29:117180. doi: 10.1016/j.atherosclerosis.2023.
PMID: 37422356